Fig. S 6 D D' D"

Bharathan NK and Dickinson AJG (2019)

Xla Wt + dsp CRISPR

NF29/30-31 (immunohistochemistry)

Anatomical Phenotype
abnormal epidermis morphology

Expression Phenotype
mislocalised krt61L expression in epidermis

skin disease

Fig. S 6 E E' E"

Bharathan NK and Dickinson AJG (2019)

Xla Wt + dsp CRISPR2

NF29/30-31 (immunohistochemistry)

Anatomical Phenotype
abnormal epidermis morphology

Expression Phenotype
mislocalised krt61L expression in epidermis

skin disease

Fig. 6 D

Bharathan NK and Dickinson AJG (2019)

Xla Wt + dsp MO

NF19-20 (immunohistochemistry)

Anatomical Phenotype
abnormal epidermis morphology abnormally localised microtubule

Expression Phenotype
mislocalised tuba4b.L expression in epidermis

skin disease

Fig. 6 I I' I''

Bharathan NK and Dickinson AJG (2019)

Xla Wt + dsp MO

NF22 (immunohistochemistry)

Anatomical Phenotype
abnormal epidermis morphology

Expression Phenotype
decreased amount cdh1.L expression in epidermis

skin disease

Fig. 6 B B' B"

Bharathan NK and Dickinson AJG (2019)

Xla Wt + dsp MO

NF29/30-31 (immunohistochemistry)

Anatomical Phenotype
abnormal epidermis morphology

Expression Phenotype
mislocalised krt61L expression in epidermis

skin disease

Fig. S 6 B B' B"

Bharathan NK and Dickinson AJG (2019)

Xla Wt + dsp MO

NF29/30-31 (immunohistochemistry)

Anatomical Phenotype
abnormal epidermis morphology

Expression Phenotype
mislocalised krt61L expression in epidermis

skin disease

Fig. 7 H

Bharathan NK and Dickinson AJG (2019)

Xla Wt + Hsa.DSPdel

NF29/30-31 (immunohistochemistry)

Expression Phenotype
decreased amount krt61L expression in cortical actin cytoskeleton

skin disease